- Home
- MNY vs ZTEK Comparison
MNY vs ZTEK Comparison
Compare MNY & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNY | ZTEK |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | Singapore | Canada |
| Employees | 240 | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.9M | 68.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | MNY | ZTEK |
|---|---|---|
| Price | $1.31 | $0.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 20.4K | ★ 176.8K |
| Earning Date | 04-30-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $0.40 |
| 52 Week High | $2.40 | $1.53 |
Technical Indicators
Market Signals| Indicator | MNY | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 46.45 | 39.88 |
| Support Level | $1.31 | $0.46 |
| Resistance Level | $1.52 | $0.56 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 38.46 | 2.33 |
Price Performance
Historical ComparisonAbout MNY MoneyHero Limited
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.